Immunoadjuvanted influenza vaccine immunogenicity in children with type 1 diabetes over two consecutive seasons
Administration of the trivalent immunoadjuvanted subunit influenza vaccine in children with T1D resulted in the formation of postvaccination Ab, meeting the Committee for Proprietary Medicinal Products (CPMP) immunogenicity criteria regardless of vaccination history.
Authors
- М. П. Костинов (ORCID: https://orcid.org/0000-0002-1382-9403)
- В. Б. Полищук (ORCID: https://orcid.org/0000-0003-0533-0909)
- А. Е. Власенко (ORCID: https://orcid.org/0000-0001-6454-4216)
- M.A. Kvasova (ORCID: https://orcid.org/0000-0002-2244-0256)
- М. Н. Локтионова
- А. М. Костинова (ORCID: https://orcid.org/0000-0002-0584-2376)
- Е. В. Колбасина
- Yu.A. Dagil (ORCID: https://orcid.org/0000-0001-9320-0789)
- А. В. Линок (ORCID: https://orcid.org/0000-0002-5980-8560)
- Е. П. Фошина (ORCID: https://orcid.org/0000-0001-7295-8072)
- А. А. Тарасова (ORCID: https://orcid.org/0000-0002-2591-6571)
- Isabella Abramovna Khrapunova
- Darya Alexandrovna Bydanova
Institutions
- Privolzhsky Research Medical University (RU)
- Sechenov University (RU)
- Nizhny Novgorod Regional Clinical Hospital named after Semashko (RU)
- Nizhny Novgorod Regional Clinical Oncology Center (RU)
- Institute of Immunology and Physiology (RU)
- Central Research Institute of Epidemiology (RU)
- Research Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences (RU)
- Digital Science Technologies (United States) (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-10-08
- DOI
- https://doi.org/10.3389/fimmu.2025.1597619
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00